Skip to main content

Heads Together Health

May 24, 2023

Heads Together Health brings a unique combination of relevant clinical expertise, an innovative technology platform and world class machine learning modeling which can make powerful impacts to patient outcomes. We have designed and developed a concussion management technology solution which … Read more

Mizar Therapeutics

May 24, 2023

Mizar Therapeutics is a platform therapeutics company using proprietary live-cell single-molecule imaging and machine-learning technology for discovery of a new class of targeted cancer therapies. Founders: Paul Maddox, Joel Smith

Delgen Biosciences

May 24, 2023

Delgen Biosciences strives to develop next-generation drug delivery technologies. To this goal, we are working to commercialize a novel polymer platform technology in creating better-in-class ophthalmic drugs and in the broader pharmaceutical space. The novel polymers designed and synthesized using … Read more

DelAQUA Pharmaceuticals

May 24, 2023

DelAQUA is a specialty pharma that has developed a breakthrough drug formulation technology that (a) reformulates marketed drugs to make them safer and more active and (b) formulates insoluble and unstable new chemical entities to make them safe and bioavailable.  … Read more

BlueSky Polymers

February 15, 2022

BlueSky Polymers is developing new chemistries for high-performance polymer material for 3D printing that can be used in both injection molding and composite materials for major industries, including aerospace, automotive, and oil and gas. Founders: Ed Samulski, Theo Dingemans

LED Radiofluidics

February 15, 2022

LED Radiofluidics, Corp. provides the imaging field easy access to cutting edge photoredox labeling technology. One arm of the company will develop simple and low-cost units that could be easily integrated into a commercial box to interface with existing cyclotrons … Read more

RainBIO

January 27, 2021

RainBio is the only ocular gene therapy pioneer focused on blindness in the cornea. Our adeno-associated virus (AAV) vector gene therapy can directly correct cornea cellular function to maintain or restore vision in patients at risk of blindness from a … Read more

CareTriage

November 20, 2020

CareTriage is a privately held, technology-enabled clinical services startup. The company provides support for value-based care by optimizing medication therapies for complex patients through prescriptive analytics and clinical pharmacist support services. The CareTriage offerings enable healthcare organizations to transition to … Read more

GeneVentiv Therapeutics

November 15, 2020

GeneVentiv Therapeutics is a pre-clinical gene therapy company focused on blood diseases and disorders. Its lead program, GENV-HEM, is the first universal gene therapy treatment for Hemophilia A and B with or without inhibitors. GENV-HEM has received Orphan Drug Designation … Read more

Eldec Pharmaceuticals

October 22, 2020

Eldec Pharmaceuticals has developed a novel, first-in-class, broad-spectrum, lung-specific immunomodulator called ELD607. ELD607 beneficially normalizes lung neutrophil levels in five different murine lung disease models. By preventing lung-damaging neutrophilia, ELD607 reduces lung damage and increases survival outcomes. In bacterial pneumonia … Read more